Allegra

   
Google
 
Web NewDrugInformation.com

Allegra


Drug - Allegra
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Fexofenadine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 60MG
The potency of the active ingredient(s), Fexofenadine Hydrochloride. May repeat for multiple part products.

Applicant - AVENTIS PHARMS
The firm name holding legal responsibility for Allegra. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020872
The FDA assigned number to Allegra. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Allegra. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 25, 2000
The date Allegra was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Allegra. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Allegra is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Allegra.

Allegra